Northwest Biotherapeutics (NWBO) Non-cash Items (2016 - 2026)

Northwest Biotherapeutics' Non-cash Items history runs 11 years deep, the most recent figure standing at -$7.5 million for Q1 2026.

• On a quarterly basis, Non-cash Items fell 312.92% year-over-year to -$7.5 million in Q1 2026; TTM through Mar 2026 was -$8.7 million, a 148.98% decrease from a year earlier, with the FY2025 full-year figure at $2.4 million, down 85.46% from the prior year.
• Non-cash Items improved to -$7.5 million in Q1 2026 per NWBO's latest filing, from -$15.2 million in the prior quarter.
• Across five years, Non-cash Items topped out at $17.0 million in Q3 2022 and bottomed at -$15.2 million in Q4 2025.
• The 5-year median for Non-cash Items is $3.5 million (2025), against an average of $4.1 million.
• Across the five-year window, Non-cash Items soared 592.87% in 2024 and plunged 355.56% in 2025, its largest moves.
• Year by year, Non-cash Items stood at $16.0 million in 2022, then slumped by 87.29% to $2.0 million in 2023, then jumped by 192.15% to $6.0 million in 2024, then plunged by 355.56% to -$15.2 million in 2025, then jumped by 50.39% to -$7.5 million in 2026.
• Per Business Quant, the three latest NWBO Non-cash Items figures stand at -$7.5 million (Q1 2026), -$15.2 million (Q4 2025), and $10.3 million (Q3 2025).